369 filings
Page 5 of 19
8-K
lcw4oiqo gl4q15iwa4
20 Feb 20
Regulation FD Disclosure
12:00am
8-K
mjwho197jwx6p0qe
19 Feb 20
Regulation FD Disclosure
8:15am
8-K
mev7ryql
9 Jan 20
Regulation FD Disclosure
4:03pm
8-K
hrtu5gogjsb
7 Jan 20
Cellectar Appoints Dr. Igor Grachev as Chief Medical Officer
4:01pm
8-K
wmyxl7lfdctbpx
6 Jan 20
Regulation FD Disclosure
4:07pm
8-K
6m1t2
19 Dec 19
Cellectar Biosciences to Present at Biotech Showcase 2020
4:03pm
8-K
5eirn7lgv74sg3l
16 Dec 19
Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio Breast Cancer Symposium
4:03pm
8-K
xxb74
9 Dec 19
Regulation FD Disclosure
4:01pm
8-K
lw49l
4 Dec 19
Cellectar Announces Oral Presentation at the 61st Annual American Society of Hematology Conference
12:00am
8-K
11s9htkg irl
12 Nov 19
Cellectar Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
8:33am
8-K
oo1nq7qqvj9jjq8 v2x
30 Oct 19
Cellectar Presents a New Phospholipid Drug Conjugate (PDC) at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
4:01pm
8-K
cu3lv3yzoidx gnj
17 Oct 19
Cellectar Announces Poster at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston
4:09pm
8-K
izoczp1o
15 Oct 19
Cellectar Presents Poster at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology
4:07pm
8-K
rkvhrzecyi4f8kh3xz6
8 Oct 19
Cellectar Announces Presentation at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology
4:01pm
8-K
grpl yke1ap0f
30 Sep 19
Cellectar Presents Data from DLBCL Cohort of its Phase 2 CLOVER-1 Study at the European Society for Medical Oncology (ESMO) Congress
4:02pm
8-K
2do6g5lsh sl818ic4
24 Sep 19
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma
4:25pm
8-K
v68 pj90dh
16 Sep 19
Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma
4:02pm
8-K
w42d57b
10 Sep 19
Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
4:42pm
8-K
mwb4a6g69r0s3
4 Sep 19
Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop
4:08pm
8-K
8s1wewueh vzc7
15 Aug 19
Cellectar Appoints Dov Elefant as Chief Financial Officer
8:30am